Claims for Patent: 8,361,536

Summary for Patent: 8,361,536

Title:	Method for fixing antibody on the surface of medical instrument
Abstract:	A method for fixing antibody on the surface of medical instrument, mainly includes: 1) pre-treating the instrument surface; 2) preparing holes: preparing multicrystal phase structure which has same size holes in the surface of the instrument by chemical corrosion, electrochemical corrosion, anodic oxidation, micro-arc oxidation, micro-arc nitridation; 3) post-treating the instrument surface; 4) fixing the antibody: immerging the bare metal scaffold which has holes in surface into a buffer solution containing antibody, adjusting the pH value of the antibody buffer solution, fixing the antibody on the surface of the instrument by the attraction between positive and negative charge and hole effect; and 5) confirming the effectiveness of the fixed antibody by artificial simulation hemodynamics and detecting method of antibody activity in scaffold surface.
Inventor(s):	Yu; Zhanjiang (Beijing, CN)
Assignee:	Lepu Medical Technology (Beijing) Co., Ltd. (Beijing, CN)
Application Number:	12/593,110
Patent Claims:	1. A method for fixing an antibody on the surface of a medical instrument, characterized in that the method includes {circle around (1)} pre-treating the instrument surface, {circle around (2)} preparing holes, {circle around (3)} post-treating the instrument surface and {circle around (4)} fixing the antibody; first, preparing a multicrystal phase structure which has the same size holes in the surface of the instrument by chemical corrosion, electrochemical corrosion, anodic oxidation, micro-arc oxidation, or micro-arc nitridation; and then immersing the bare metal scaffold which has holes in the surface into a buffer solution containing the antibody, adjusting the pH value of the antibody buffer solution, fixing the antibody on the surface of the instrument by the attraction between positive and negative charge and hole effect; and finally, confirming the effectiveness of the fixed antibody by artificial simulation hemodynamics and detecting method of antibody activity on the scaffold surface. 2. The method for fixing an antibody on the surface of a medical instrument according to claim 1, characterized in that the step {circle around (1)} pre-treating the instrument surface includes: washing the instrument surface by ultrasonication to remove impurities, using analytical reagent acetone solution at a concentration of 99.5% or medical ethanol solvent at a concentration of 75% to wash the scaffold body material for 5 to 15 minutes using 28 to 100 khz ultrasonication to remove the impurities on the body material, putting the washed body material in a dryer to dry at 30 to 40.degree. C. for 30 to 60 minutes, and then taking out the body material for reservation. 3. The method for fixing an antibody on the surface of a medical instrument according to claim 1, characterized in that the step {circle around (2)} preparing holes includes: directly preparing holes of the same size in the instrument by acid solution corrosion; immersing the instrument material into the corrosion solution at 0 to 100.degree. C.; and the corrosion solution is preferably hydrochloric acid at a concentration of 1 to 38% or hydrochloric acid mixed acid solution containing 1 to 38% hydrochloric acid mixed with 1 to 98% vitriol; and then forming single nanometer-size holes after corrosion for 1 minute to 480 hours; the corrosion time varies according to the concentration and temperature. 4. The method for fixing an antibody on the surface of a medical instrument according to claim 1, characterized in that the step {circle around (3)} post-treating the instrument surface includes: using 99.5% analytical reagent acetone solution and distilled water in sequence to wash the body material for 5 to 15 minutes using 28 to 100 khz ultrasonication; and finally putting the washed body material in a dryer to dry at 30 to 40.degree. C. for 30 to 60 minutes, and then taking out the body material for reservation, or preparing 1 to 38% hydrochloric acid solution with distilled water and then immersing the body material into the prepared solution and putting the solution containing the body material into an incubator at 20.degree. C. and then taking out the body material after 30 minutes to 48 hours. 5. The method for fixing an antibody on the surface of a medical instrument according to claim 1, characterized in that the instrument includes scaffold, catheter, guide wire, heart pacemakers, heart valves, surgical implant materials, implant hard tissue, and non-metal medical instrument whose substrate is ceramics, organic polymer, inorganic substance or metal oxide; the scaffold is balloon-expandable, self-expanding, vessel or non-vessel stent, stent whose substrate is stainless steel, nickel-titanium memory alloy, cobalt-based alloy, titanium or titanium alloy; and the scaffold made by wire weaving, tube laser cutting, die casting or welding. 6. The method for fixing an antibody on the surface of a medical instrument according to claim 1, characterized in that the biological product antibodies include one or more of the following substances: heparin, anti-platelet membrane glycoprotein (GPIIb/IIIa) receptor antagonists, antibody-treating cancer drug, abciximab, biological peptides, CD34 antibody, CD31 antibody and CD133 antibody. 7. The method for fixing an antibody on the surface of a medical instrument according to claim 1, characterized in that the step {circle around (4)} fixing the antibody includes: (1) immersing the scaffold which has holes in surface into the phosphate buffer solution or the carbonate buffer solution containing 0.1 to 100 .mu.g/mL CD34 antibody to incubate for 20 to 60 minutes at 25 to 37.degree. C. and then taking out the scaffold; (2) washing the scaffold 3 times for 5 minutes per time using the phosphate buffer solution and blowing the scaffold for 15 minutes at room temperature and then preserving the scaffold at 4.degree. C. after it becomes dry. 8. The method for fixing an antibody on the surface of a medical instrument according to claim 1, characterized in that conducting step {circle around (5)} directly detecting the antibody activity after fixing the antibody includes: performing fluorescence coloring through the specific reaction of CD34 antigen-antibody using fluorescein isothiocyanate (FITC) labeled mouse anti-human CD34 antibody and detecting the antibody activity on the scaffold surface by photo-detection of fluorescence using fluorescence microscope. 9. The method for fixing an antibody on the surface of a medical instrument according to claim 1, characterized in that after the step {circle around (4)} fixing the antibody, step {circle around (6)} indirectly detecting the antibody activity is conducted: detecting the antibody activity on the scaffold surface using 3-amino-9-ethyl-carbazole (AEC) staining kit after the antibody is cascade amplified by horseradish peroxidase (HRP) labeled goat anti-mouse IgG secondary antibody. 10. The method for fixing an antibody on the surface of a medical instrument according to claim 1 is characterized in that after the step {circle around (4)} fixing the antibody, step {circle around (7)} detecting the content of the antibody on surface is conducted: indirectly detecting the content of the antibody on the scaffold surface by tetramethylbenzidine (TMB) chromogenic after cascade amplification of goat anti-mouse IgG secondary antibody labeled by horseradish peroxidase (HRP); the steps are as follows: (1) immersing the scaffold with antibody on surface into the phosphate buffer solution containing 500 .mu.L of 5 to 10% bovine serum albumin (BSA) to incubate at 25 to 37.degree. C. for 30 minutes to 2 hours and then taking out the scaffold to dry in the air; (2) immersing the scaffold into the phosphate buffer solution containing horseradish peroxidase (HRP) labeled goat anti-mouse IgG to incubate at 25 to 37.degree. C. for 20 to 30 minutes and then taking out the scaffold; (3) washing the scaffold 3 times for 5 minutes per time with the phosphate buffer solution; putting the scaffold into 500 .mu.L TMB substrate buffer solution; the 500 .mu.L TMB substrate buffer solution is made of, such as, 0.5 mL anhydrous ethanol of 10 mg/5 mL mixed with 5 mL substrate buffer solution; the substrate buffer solution is made of, such as, 1.42 g Na.sub.2HPO.sub.4 mixed with 0.96 g sodium citrate which is added distilled water to 50 mL; after washing, adding 32 .mu.L hydrogen peroxide of 0.75% into the phosphate buffer solution to incubate for 15 minutes and then adding 250 .mu.L 2 M sulfuric acid solution to terminate the reaction; (4) using a microplate reader to measure the absorbance of the solution at 492 nm; coating CD34 antibody having a known concentration on an ELISA plate according to the different concentration gradients of 1:10, 1:20, 1:50, 1:100, 1:500, 1:1000, and 1:10000, and then drawing a standard curve by simulation of the concentration of CD34 antibody with A492 nm; (5) determining the amount of the antibody on the scaffold surface according to the measured absorbance and the standard curve; the result showed that 316L stainless steel stent with holes can fix 1 to 20 ng CD34 antibody each 1 mm in length. 11. The method for fixing an antibody on the surface of a medical instrument according to claim 1, characterized in that after the step {circle around (4)} fixing the antibody, step {circle around (8)} detecting the firmness of the antibody is conducted: putting the scaffold that has the fixed mouse anti-human CD34 antibody on surface into fluid artificial simulated body fluid, such as the phosphate buffer solution whose pressure is 100 mmHg and flow rate is 91 cm/s, performing a scouring experiment, when the scaffold is in a normal state or in a state after the balloon dilation; finally, using the method described in step {circle around (6)} to detect the antibody activity on the scaffold surface and using the method of step {circle around (7)} to quantify the antibody on the scaffold.

Details for Patent 8,361,536

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	REOPRO	abciximab	Injection	103575	12/22/1994		2027-05-23